Correct me if I'm wrong but isn't this the first time we're hearing about using BTX1801 for treatment for patients using a dialysis machine? If successful, this would prove antimicrobial effect systemically in the bloodstream which would open a pathway for use in all patients with any infection not just people with kidney issues. Thinking out loud here..
Ann: Botanix Update on BTX 1801 Clinical Development, page-4
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.3¢ |
Change
0.003(0.60%) |
Mkt cap ! $761.8M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 43.0¢ | 42.0¢ | $1.083M | 2.574M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 323027 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 48017 | 3 |
View Market Depth
| Last trade - 10.25am 16/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |